88 related articles for article (PubMed ID: 24419512)
1. Expression of caveolin-1 and podocalyxin in rat lungs challenged with 2-kDa macrophage-activating lipopeptide and Flt3L.
Tschernig T; Pabst R; Kasper M; El-Hadi M; Singh B
Cell Tissue Res; 2014 Apr; 356(1):207-16. PubMed ID: 24419512
[TBL] [Abstract][Full Text] [Related]
2. Local pulmonary immune stimulation by the Toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependent.
Lührmann A; Grote K; Stephan M; Tschernig T; Pabst R
Immunol Lett; 2007 Feb; 108(2):167-73. PubMed ID: 17275100
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.
Schill T; Schön MP; Pletz N; Emmert S; Schön M
Exp Dermatol; 2012 Feb; 21(2):91-8. PubMed ID: 22044500
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa.
Kerber-Momot T; Leemhuis D; Lührmann A; Munder A; Tümmler B; Pabst R; Tschernig T
Inflammation; 2010 Feb; 33(1):58-64. PubMed ID: 19844782
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.
Reppe K; Tschernig T; Lührmann A; van Laak V; Grote K; Zemlin MV; Gutbier B; Müller HC; Kursar M; Schütte H; Rosseau S; Pabst R; Suttorp N; Witzenrath M
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):474-81. PubMed ID: 18931326
[TBL] [Abstract][Full Text] [Related]
6. In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application.
Lührmann A; Deiters U; Skokowa J; Hanke M; Gessner JE; Mühlradt PF; Pabst R; Tschernig T
Infect Immun; 2002 Jul; 70(7):3785-92. PubMed ID: 12065522
[TBL] [Abstract][Full Text] [Related]
7. In vivo administration of Fms-like tyrosine kinase-3 ligand effectively stimulates lung dendritic cell expansion in mice.
Wang HW; Lu JY; Wang L; Tian G
Chin Med J (Engl); 2012 Jul; 125(14):2562-7. PubMed ID: 22882940
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of bronchus-associated lymphoid tissue in rats by repeated inhalation of aerosolized lipopeptide MALP-2.
Lührmann A; Tschernig T; Pabst R
Pathobiology; 2002-2003; 70(5):266-9. PubMed ID: 12771507
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-activating lipopeptide-2 downregulates the expression of ATP-binding cassette transporter A1 by activating the TLR2/NF-кB/ZNF202 pathway in THP-1 macrophages.
Peng L; Zhang Z; Zhang M; Yu X; Yao F; Tan Y; Liu D; Gong D; Chong H; Liu X; Zheng X; Tian G; Tang C
Acta Biochim Biophys Sin (Shanghai); 2016 Apr; 48(4):363-70. PubMed ID: 26922321
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.
Grote K; Sonnenschein K; Kapopara PR; Hillmer A; Grothusen C; Salguero G; Kotlarz D; Schuett H; Bavendiek U; Schieffer B
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2097-104. PubMed ID: 23868938
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of lymphocytes and dendritic cells from the blood to the bronchoalveolar space and the draining lymph nodes after a single intrabronchial application of the lipopeptide MALP-2.
Tschernig T; Lührmann A; Pabst R
Pathobiology; 2002-2003; 70(5):260-5. PubMed ID: 12771506
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-activating lipopeptide-2 (MALP-2) induces a localized inflammatory response in rats resulting in activation of brain sites implicated in fever.
Knorr C; Hübschle T; Murgott J; Mühlradt P; Gerstberger R; Roth J
Brain Res; 2008 Apr; 1205():36-46. PubMed ID: 18353287
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
14. Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2.
Sawahata R; Shime H; Yamazaki S; Inoue N; Akazawa T; Fujimoto Y; Fukase K; Matsumoto M; Seya T
Microbes Infect; 2011 Apr; 13(4):350-8. PubMed ID: 21172450
[TBL] [Abstract][Full Text] [Related]
15. Macrophage activating lipopeptide 2 is effective in mycobacterial lung infection.
Tschernig T; Pabst R
Ann Anat; 2021 Jan; 233():151605. PubMed ID: 32949720
[TBL] [Abstract][Full Text] [Related]
16. The Lipopeptide MALP-2 Promotes Collateral Growth.
Troidl K; Schubert C; Vlacil AK; Chennupati R; Koch S; Schütt J; Oberoi R; Schaper W; Schmitz-Rixen T; Schieffer B; Grote K
Cells; 2020 Apr; 9(4):. PubMed ID: 32316253
[TBL] [Abstract][Full Text] [Related]
17. Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2.
Liao D; Su X; Wang J; Yu J; Luo H; Tian W; Ye Z; He J
Front Immunol; 2023; 14():1113715. PubMed ID: 36761746
[No Abstract] [Full Text] [Related]
18. Synthetic mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells.
Weigt H; Mühlradt PF; Emmendörffer A; Krug N; Braun A
Immunobiology; 2003; 207(3):223-33. PubMed ID: 12777064
[TBL] [Abstract][Full Text] [Related]
19. The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissues.
Rharbaoui F; Westendorf A; Link C; Felk S; Buer J; Gunzer M; Guzmán CA
Infect Immun; 2004 Dec; 72(12):6978-86. PubMed ID: 15557620
[TBL] [Abstract][Full Text] [Related]
20. Lung dendritic cells elicited by Fms-like tyrosine 3-kinase ligand amplify the lung inflammatory response to lipopolysaccharide.
von Wulffen W; Steinmueller M; Herold S; Marsh LM; Bulau P; Seeger W; Welte T; Lohmeyer J; Maus UA
Am J Respir Crit Care Med; 2007 Nov; 176(9):892-901. PubMed ID: 17690334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
